HopeStage
Back to all studies
CompletedNCT00320047

Baclofen for binge eating and food cravings

About this title

Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder

Read the official source — NCT00320047
Medication studyAges 18–55United StatesEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
New YorkSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2005
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT00320047
Official title
Show the full official title

Effects of Baclofen on Binge Eating in Bulimia Nervosa and Binge Eating Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Baclofen.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies